Journal of obstetrics and gynaecology of India · 2024
A Non-Inferiority Study on Endometrial Preparation Prior to FET-Letrozole Versus Hormone Replacement Therapy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Makay Özer, Özçınar Beyza, Şimşek Turgay, Arıcı Cumhur, Güngör Bülent, Özbaş Serdar, Akça Tamer, Emre Ali Uğur, Karadeniz Çakmak Güldeniz, Akçay Müfide, Ünal Bülent, Girgin Mustafa, Girgin Sadullah, Görgülü Semih, Sezer Atakan, Karataş Adem, Özemir İbrahim Ali, Aksakal Nihat, Erel Serap, Uğurlu M Ümit, Filiz Ali İlker, Atalay Can, Uzunköy Ali, Deveci Uğur, Kotan Çetin, İçöz Gökhan, Kurt Yavuz, Kebudi Abut, Cantürk N Zafer, Erbil Yeşim, Pandev Rumen, Güllüoğlu Bahadır M
Аннотация
OBJECTIVE: To evaluate the frequency, clinical associations and prognostic impact of hyponatraemia on cirrhosis related complications in patients with cirrhosis of liver.
METHODS: In this case control study 217 cirrhotic patients consecutively admitted to our department from September 2006 to November 2007 were studied. Serum sodium levels were determined in all patients admitted. The cutoff level of 130 meq/l was chosen because it is widely accepted to define hyponatraemia in patients with cirrhosis while the level of 135 meq/L is the lower normal value. Patients were grouped on the basis of serum sodium concentration into (1) serum sodium <130 meq/L (Group 1) (2) serum sodium between 131 - 135 meq/l (Group 2), and (3) serum sodium >135 meq/l (Group 3). P values of less than 0.05 were considered as significant. The patients with hyponatraemia Group 1 (<130 meq/l) and group 2 (131-135 meq/l) were compared with group 3 (>135 meq/l) for the severity of liver disease, degree of ascites and other cirrhosis related complications such as hepatorenal syndrome, spontaneous bacterial peritonitis and hepatic encephalopathy.
RESULTS: This case control study constituted 217 consecutive cirrhotic patients of which 141 (65%) were male and 76/217 (35%) were female. Hyponatraemia (sodium <130 meq/l) was found in 58/217 (26.7%) patients and 54/217 (24.9%) had serum sodium from 131-135 meq/l whereas 105/217 (48.4%) patients had serum sodium >135. Out of 58 patients with hyponatraemia, 48 were in Child-Pugh C class (p=0.001). Patients with serum sodium <130 meq/l had more severe ascites (p = 0.001) requiring frequent paracentesis and higher dosages of diuretics. Hepatic encephalopathy was more frequent in patients with serum sodium <130 meq/l (p= 0.001). The cirrhosis related complications were also significantly increased in patients with mild hyponatraemia (131-135 meq/l) than in patients with normal serum sodium (>135 meq/l).
CONCLUSION: Hyponatraemia is frequent in cirrhotic patients. It is seldom spontaneous and has a negative influence on cirrhosis related complications.
METHODS: In this case control study 217 cirrhotic patients consecutively admitted to our department from September 2006 to November 2007 were studied. Serum sodium levels were determined in all patients admitted. The cutoff level of 130 meq/l was chosen because it is widely accepted to define hyponatraemia in patients with cirrhosis while the level of 135 meq/L is the lower normal value. Patients were grouped on the basis of serum sodium concentration into (1) serum sodium <130 meq/L (Group 1) (2) serum sodium between 131 - 135 meq/l (Group 2), and (3) serum sodium >135 meq/l (Group 3). P values of less than 0.05 were considered as significant. The patients with hyponatraemia Group 1 (<130 meq/l) and group 2 (131-135 meq/l) were compared with group 3 (>135 meq/l) for the severity of liver disease, degree of ascites and other cirrhosis related complications such as hepatorenal syndrome, spontaneous bacterial peritonitis and hepatic encephalopathy.
RESULTS: This case control study constituted 217 consecutive cirrhotic patients of which 141 (65%) were male and 76/217 (35%) were female. Hyponatraemia (sodium <130 meq/l) was found in 58/217 (26.7%) patients and 54/217 (24.9%) had serum sodium from 131-135 meq/l whereas 105/217 (48.4%) patients had serum sodium >135. Out of 58 patients with hyponatraemia, 48 were in Child-Pugh C class (p=0.001). Patients with serum sodium <130 meq/l had more severe ascites (p = 0.001) requiring frequent paracentesis and higher dosages of diuretics. Hepatic encephalopathy was more frequent in patients with serum sodium <130 meq/l (p= 0.001). The cirrhosis related complications were also significantly increased in patients with mild hyponatraemia (131-135 meq/l) than in patients with normal serum sodium (>135 meq/l).
CONCLUSION: Hyponatraemia is frequent in cirrhotic patients. It is seldom spontaneous and has a negative influence on cirrhosis related complications.